mecamylamine has been researched along with Acute Lung Injury in 1 studies
Mecamylamine: A nicotinic antagonist that is well absorbed from the gastrointestinal tract and crosses the blood-brain barrier. Mecamylamine has been used as a ganglionic blocker in treating hypertension, but, like most ganglionic blockers, is more often used now as a research tool.
Acute Lung Injury: A condition of lung damage that is characterized by bilateral pulmonary infiltrates (PULMONARY EDEMA) rich in NEUTROPHILS, and in the absence of clinical HEART FAILURE. This can represent a spectrum of pulmonary lesions, endothelial and epithelial, due to numerous factors (physical, chemical, or biological).
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 0 (0.00) | 29.6817 |
2010's | 1 (100.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Kox, M | 1 |
Pompe, JC | 1 |
Peters, E | 1 |
Vaneker, M | 1 |
van der Laak, JW | 1 |
van der Hoeven, JG | 1 |
Scheffer, GJ | 1 |
Hoedemaekers, CW | 1 |
Pickkers, P | 1 |
1 other study available for mecamylamine and Acute Lung Injury
Article | Year |
---|---|
α7 nicotinic acetylcholine receptor agonist GTS-21 attenuates ventilator-induced tumour necrosis factor-α production and lung injury.
Topics: Acute Lung Injury; alpha7 Nicotinic Acetylcholine Receptor; Animals; Benzylidene Compounds; Cholines | 2011 |